Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 4, 2010, Pages 1236-1243

  Godin, Biana ^a   Gu, Jianhua ^a   Serda, Rita E ^a   Bhavane, Rohan ^a   Tasciotti, Ennio ^a   Chiappini, Ciro ^a   Liu, Xuewu ^a   Tanaka, Takemi ^a   Decuzzi, Paolo ^b,c   Ferrari, Mauro ^a,d,e  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b University of Texas School of Health Information Sciences at Houston   (United States)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Rice University   (United States)

Author keywords

Biocompatibility; Biodegradation; Mesoporous silicon; Polyethylene glycol

Indexed keywords

BIOTHERAPEUTICS; CONTROLLED DELIVERY; COVALENT ATTACHMENT; DEGRADATION KINETICS; ENDOTHELIAL SYSTEMS; FLUORIMETRY; HUMAN MACROPHAGES; ICP-AES; IN-VITRO; MESOPOROUS SILICON; MICRO-PARTICLES; PEGYLATION; PHYSIOLOGICAL CONDITION; PROINFLAMMATORY CYTOKINES; SEM; SILICON STRUCTURES; SURFACE MODIFIERS;

ATOMIC EMISSION SPECTROSCOPY; BIOCOMPATIBILITY; BIODEGRADATION; DEGRADATION; MACROPHAGES; MICROBIOLOGY; POLYETHYLENE OXIDES; POLYETHYLENES; THERMOPLASTICS;

POLYETHYLENE GLYCOLS;

INTERLEUKIN 6; INTERLEUKIN 8; MACROGOL; SILICON;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; BIOCOMPATIBILITY; DEGRADATION KINETICS; FLUOROMETRY; HUMAN; HUMAN CELL; MACROPHAGE; MOLECULAR WEIGHT; SCANNING ELECTRON MICROSCOPY; SIMULATION; ZETA POTENTIAL;

CELL LINE; FLUORESCENCE; HUMANS; HYDROGEN-ION CONCENTRATION; INTERLEUKIN-8; KINETICS; MACROPHAGES; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POROSITY; SILICON;

EID: 77956484230     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32807     Document Type: Article

References (26)

1. Uhlir A. Electrolytic shaping of germanium and silicon. Bell Syst Tech J 1956;35:333-347.
2. Nijdam AJ, Ming-Cheng Cheng M, Geho DH, Fedele R, Herrmann P, Killian K, Espina V, Petricoin EF, Liotta LA, Ferrari M. Physicochemically modified silicon as a substrate for protein microarrays. Biomaterials 2007;28:550-558. (Pubitemid 44740106)
3. Nijdam AJ, Zianni MR, Herderick EE, Cheng MM, Prosperi JR, Robertson FA, Petricoin EF, Liotta LA, Ferrari M. Application of physicochemically modified silicon substrates as reverse-phase protein microarrays. J Proteome Res 2009;8:1247-1254.
4. Lehmann V, Gosele U. Porous silicon formation: A quantum wire effect. Appl Phys Lett 1991;58:656-658.
5. Lin VS, Motesharei K, Dancil KP, Sailor MJ, Ghadiri MR. A porous silicon-based optical interferometric biosensor. Science 1997;278:840-843.
6. Li YY, Cunin F, Link JR, Gao T, Betts RE, Reiver SH, Chin V, Bhatia SN, Sailor MJ. Polymer replicas of photonic porous silicon for sensing and drug delivery applications. Science 2003;299:2045-2047. (Pubitemid 36383727)
7. Tasciotti E, Liu X, Bhavane R, Plant K, Leonard AD, Price BK, Cheng MM, Decuzzi P, Tour JM, Robertson F. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 2008;3:151-157.
8. Sharma S, Nijdam AJ, Sinha PM, Walczak RJ, Liu X, Cheng MM, Ferrari M. Controlled-release microchips. Expert Opin Drug Deliv 2006;3:379-394.
9. Salonen J, Laitinen L, Kaukonen AM, Tuura J, Bjorkqvist M, Heikkila T, Vaha-Heikkila K, Hirvonen J, Lehto VP. Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs. J Controlled Release 2005;108:362-374.
10. Brumm MV, Nguyen QD. Fluocinolone acetonide intravitreal sustained release device - A new addition to the armamentarium of uveitic management. Int J Nanomed 2007;2:55-64.
11. Goh AS, Chung AY, Lo RH, Lau TN, Yu SW, Chng M, Satchithanantham S, Loong SL, Ng DC, Lim BC. A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorous32 (32P) brachytherapy delivery device - A first-in-man study. Int J Radiat Oncol Biol Phys 2007;67:786-792.
12. Canham LT, Reeves CL, Newey JP, Houlton MR, Cox TI, Buriak JM, Stewart MP. Derivatized mesoporous silicon with dramatically improved stability in simulated human blood plasma. Adv Mater 1999;11:1505-1507.
13. Canham LT. Bioactive silicon structure fabrication through nanoetching techniques. Adv Mater 1995;7:1033-1037.
14. Immordino ML, Dosio F, Cattel L. Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006;1:297-315.
15. Wattendorf U, Merkle HP. PEGylation as a tool for the biomedical engineering of surface modified microparticles. J Pharm Sci 2008;97:4655-4669.
16. Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H. Nanomedicine - Challenge and perspectives. Angew Chem Int Ed Engl 2009;48:872-897.
17. Serda RE, Gu J, Bhavane RC, Liu X, Chiappini C, Decuzzi P, Ferrari M. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 2009;30:2440-2448.
18. Jugdaohsingh R, Anderson SH, Tucker KL, Elliott H, Kiel DP, Thompson RP, Powell JJ. Dietary silicon intake and absorption. Am J Clin Nutr 2002;75:887-893.
19. Carlisle EM. Silicon: A possible factor in bone calcification. Science 1970;167:279-280.
20. Buriak JM, Allen MJ. Lewis acid mediated functionalization of porous silicon with substituted alkenes and alkynes. J Am Chem Soc 1998;120:1339-1340.
21. Absher MP, Trombley L, Hemenway DR, Mickey RM, Leslie KO. Biphasic cellular and tissue response of rat lungs after eight-day aerosol exposure to the silicon dioxide cristobalite. Am J Pathol 1989;134:1243-1251. (Pubitemid 19206311)
22. Kolb-Bachofen V. Uptake of toxic silica particles by isolated rat liver macrophages (Kupffer cells) is receptor mediated and can be blocked by competition. J Clin Invest 1992;90:1819-1824.
23. Wilson J, Pigott GH, Schoen FJ, Hench LL. Toxicology and biocompatibility of bioglasses. J Biomed Mater Res 1981;15:805-817.
24. Palumbo G, Avigliano L, Strukul G, Pinna F, Del Principe D, D'angelo I, Annicchiarico-Petruzzelli M, Locardi B, Rosato N. Fibroblast growth and polymorphonuclear granulocyte activation in the presence of a new biologically active sol-gel glass. J Mater Sci Mater Med 1997;8:417-421.
25. Alvarez SD, Derfus AM, Schwartz MP, Bhatia SN, Sailor MJ. The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors. Biomaterials 2009;30:26-34.
26. Chin V, Collins BE, Sailor MJ, Bhatia SN. Compatibility of primary hepatocytes with oxidized nanoporous silicon. Adv Mater 2001;13:1877-1880.